Przejdź do zawartości
Merck

MABE2186

Anti-KDM3A/JMJD1A Antibody, clone F0231

Synonim(y):

EC:1.14.11.65, Jhdm2a, JmjC domain-containing histone demethylation protein 2A, Jmjd1a, Jumonji domain-containing protein 1A, Kiaa0742, Lysine-specific demethylase 3A, [histone H3]-dimethyl-L-lysine(9) demethylase 3A

Zaloguj się, aby wyświetlić ceny organizacyjne i kontraktowe.

Wybierz wielkość

Zmień widok

Informacje o tej pozycji

UNSPSC Code:
12352203
NACRES:
NA.46
Clone:
F0231, monoclonal
Species reactivity:
mouse
Application:
ChIP, IP, WB
Citations:
-
Pomoc techniczna
Potrzebujesz pomocy? Nasz zespół doświadczonych naukowców chętnie Ci pomoże.
Pozwól nam pomóc


biological source

mouse

Quality Segment

antibody form

purified antibody

antibody product type

primary antibodies

clone

F0231, monoclonal

mol wt

calculated mol wt 147.85 kDa, observed mol wt ~158 kDa

purified by

using protein G

species reactivity

mouse

packaging

antibody small pack of 100

technique(s)

ChIP: suitable, immunoprecipitation (IP): suitable, western blot: suitable

isotype

IgG2aκ

epitope sequence

C-terminal half

Protein ID accession no.

UniProt accession no.

storage temp.

2-8°C

Gene Information

mouse ... Kdm3a(104263)

General description

Lysine-specific demethylase 3A (UniProt: Q6PCM1; also known as EC:1.14.11.65, JmjC domain-containing histone demethylation protein 2A, Jumonji domain-containing protein 1A, [histone H3]-dimethyl-L-lysine(9) demethylase 3A) is encoded by the Kdm3a (also known as Jhdm2a, Jmjd1a, Kiaa0742) gene (Gene ID: 104263) in mouse. KDM3A is a member of the Jumonji C (JmjC) domain-containing family of histone demethylases. KDM3A contains a C-terminal JmjC domain that catalyzes the demethylation of mono- and di-methylated lysine 9 on histone H3 (H3K9me1/me2), a modification associated with transcriptional repression. In addition, it contains a zinc-finger domain for DNA binding and an LXXLL motif for interacting with nuclear receptors. As a result of KDM3A demethylation of H3K9me1/me2, gene transcription increases. This enzymatic activity plays a crucial role in regulating gene expression by altering chromatin structure, thereby influencing various biological processes such as cell differentiation, proliferation, spermatogenesis, energy metabolism, stem cell regulation, and development. JMJD1A is also involved in beige adipogenesis through a multistep process where phosphorylation of S265 of JMJD1A stimulates its H3K9me2 demethylase activity that ultimately results in the thermogenic gene regulation in beige adipogenesis. KDM3A is expressed in a wide range of tissues, with particularly high levels in the testes, reflecting its role in spermatogenesis. The involvement of KDM3A in disease has been increasingly recognized, particularly in cancer, where it is often overexpressed and contributes to tumor progression by activating oncogenes and promoting cell cycle progression. Additionally, KDM3A has been implicated in metabolic disorders and cardiovascular diseases. The therapeutic potential of targeting KDM3A in disease contexts is an area of active research. (Ref.: Takahashi, H., et al. (2022). Nat Commun. 13(1);5715; Yoo, J., et al., (2020), Cancers, 12(5), 1098)

Immunogen

Recombinant protein corresponding to 51 amino acids from the C-terminal half of mouse KDM3A/JMJD1A.

Application

Quality Control Testing

Evaluated by Western Blotting in NIH/3T3 cell lysate.

Western Blotting Analysis: A 1:1,000 dilution of this antibody detected KDM3A/JMJD1A in NIH/3T3 cell lysate.






Tested Applications

Western Blotting Analysis: A representative lot detected KDM3A/JMJD1A in Western Blotting application (Takahashi, H., et al. (2022). Nat Commun. 13(1);5715).

Immunoprecipitation Analysis: A representative lot immunoprecipitated KDM3A/JMJD1A in lysate from 3T3-L1 pre-adipocytes. (Takahashi, H., et al. (2022). Nat Commun. 13(1);5715).

Chromatin Immunoprecipitation (ChIP) Analysis: A representative lot detected KDM3A/JMJD1A in Chromatin Immunoprecipitation application (Takahashi, H., et al. (2022). Nat Commun. 13(1);5715).

ChIP-seq: A representative lot detected KDM3A/JMJD1A in ChIP-seq application (Takahashi, H., et al. (2022). Nat Commun. 13(1);5715).

Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user.

Biochem/physiol Actions

Clone F0231 is a mouse monoclonal antibody that detects KDM3A/JMJD1A. It targets an epitope within 51 amino acids from the C-terminal half.

Physical form

Purified mouse monoclonal antibody IgG2a in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.

Preparation Note

1.0 mg/mL. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.
Recommended storage: +2°C to +8°C.

Other Notes

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Ta strona może zawierać tekst przetłumaczony maszynowo.


Still not finding the right product?

Wypróbuj nasze narzędzie Narzędzie selektora produktów, aby zawęzić opcje.


Klasa składowania

12 - Non Combustible Liquids

Co się dzieje?

WGK 3

Temperatura zapłonu (°F)

Not applicable

Temperatura zapłonu (°C)

Not applicable



Wybierz jedną z najnowszych wersji:

Certyfikaty analizy (CoA)

Lot/Batch Number

Nie widzisz odpowiedniej wersji?

Jeśli potrzebujesz konkretnej wersji, możesz wyszukać konkretny certyfikat według numeru partii lub serii.

Masz już ten produkt?

Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.

Odwiedź Bibliotekę dokumentów